SibbarPharma AB

ABActive

Org 5590038906Skånegatan 20, 216 11 LimhamnResearch and experimental development on natural sciences and engineering · NACE 7210Est. 20150 employees

Overview Financials People & ownership Related companies

SibbarPharma AB is a Swedish AB based in Limhamn, operating in the Annan naturvetenskaplig och teknisk forskning och utveckling sector. Incorporated in 2015, the company has 0 employees and reported revenue of SEK 1,4M in its latest annual filing.

Revenue 2024

SEK 1,4M

+38% vs 2023

EBITDA margin

78.8%

+55% vs 2023

Equity ratio

44.9%

Financial strength

Net profit 2024

SEK 718K

+39% vs 2023

EBITDA — year on year

SEK millions

Key figures

Annual report 2024

Revenue	SEK 1,4M	+38%
EBITDA	SEK 1,1M	+55%
Net profit	SEK 718K	+39%
Total assets	SEK 3,9M	+28%
Equity	SEK 1,8M	+21%
Employees	0	—

Contact

Address

Skånegatan 20, 216 11 Limhamn

drbengtlindberg@yahoo.com

Risika for professionals

Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.

Visit risika.com

Frequently asked questions

What is the Org number of SibbarPharma AB?

SibbarPharma AB is registered with Bolagsverket / SCB under Org 5590038906.

What is the revenue of SibbarPharma AB?

SibbarPharma AB reported revenue of SEK 1,4M in 2024.

Who is the CEO of SibbarPharma AB?

Eva Anna Katarina Lindberg is Chief Executive Officer of SibbarPharma AB, in role since 2022.

Who is the chairman of SibbarPharma AB?

Erik Ernst Hubert Lindberg chairs the board of SibbarPharma AB, in role since 2020.

Where is SibbarPharma AB headquartered?

SibbarPharma AB's registered address is Skånegatan 20.

SibbarPharma AB

EBITDA — year on year

Key figures

Company information

Contact

Frequently asked questions

More on SibbarPharma AB

EBITDA — year on year

Key figures

Company information

Contact

Frequently asked questions

More on SibbarPharma AB